PHARMA MIX M 300

ACTIVE HALF-LIFE 5-6 days
CLASSIFICATION Anabolic Steroid
DOSAGE Men: 300-900 mg/week
ACNE Yes
WATER RETENTION Low
HBR No
HEPATOTOXICITY Low
AROMATIZATION No
CARRIER OIL Grapeseed Oil
MANUFACTURER Pharmacom Labs - US
LAB TEST Available upon request
WAREHOUSE USA Warehouse 4
SUBSTANCE Drostanolone Enanthate, Drostanolone Propionate

Introducing PHARMAMIX M 300, a powerful fusion of two drostanolone esters: propionate and enanthate. This innovative formulation is designed for those seeking to achieve high-quality lean muscle mass and a sculpted physique, while effectively managing excess subcutaneous water retention often linked with long esters. PHARMAMIX M 300 works seamlessly with testosterone and trenbolone combinations (PHARMA SUST 300, 500, PHARMA 3-TREN) alongside long-acting testosterone and trenbolone variants (PHARMA TEST E300, E500, C250; PHARMA TREN E200, H100). For those looking for similar benefits, check out our successful product, PHARMA MIX 6, which mirrors the popularity of PHARMA MIX 2.

First introduced in 1959 by Syntex and hitting the market in 1970 under the brand name Masteron, drostanolone is an injectable anabolic steroid derived from dihydrotestosterone (DHT). Esteemed for its robust anabolic properties and anti-estrogenic traits, drostanolone was FDA-approved for treating inoperable breast cancer in postmenopausal women, a testament to its therapeutic versatility.

Biologically, Masteron mimics DHT, showcasing its most effective results during cutting cycles. To fully harness its advantages, users should ideally be at a low body fat percentage. Drostanolone is non-aromatizing, meaning it does not cause water retention, and offers a mild diuretic effect akin to stanozolol, enhancing muscle density, definition, and overall appearance. This compound supports optimal muscle conditioning, primarily due to its lipolytic properties, facilitating a body fat reduction of around 5-7%. It's particularly favored by track and field athletes and bodybuilders who aim to stay within their weight classes.

While Masteron may offer modest bulking effects, akin to those from Primobolan at higher doses, other anabolic steroids may be more effective for significant mass gains. Importantly, Masteron does not convert to estrogen, exhibiting anti-estrogenic properties by binding to aromatase, which is one reason for its application in breast cancer therapies.

In summary, drostanolone provides benefits similar to stanozolol, without the side effects commonly associated with Winstrol. It avoids increasing tendon brittleness, depleting joint fluid, and poses fewer negative impacts on blood cholesterol levels. Therefore, for those in search of a cutting agent, drostanolone emerges as a safer and more effective alternative to stanozolol.